Commission Decision
of 27 November 2009
amending Decision 2002/364/EC on common technical specifications for in vitro diagnostic medical devices
(notified under document C(2009) 9464)
(Text with EEA relevance)
(2009/886/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Whereas:
In the interest of public health and in order to reflect technical progress including the evolution in the performance and analytical sensitivity of devices, it is appropriate to revise the common technical specifications laid down in Decision 2002/364/EC.
The definition of rapid test should be refined in order for it to be more precise. For the sake of clarity further definitions should be included.
To bring the common technical specifications in line with current scientific and technical practices it is necessary to update a number of scientific and technical references.
The requirements for HIV screening assays should be clarified. In order to ensure that the performance criteria appropriate to today’s technology is reflected in the common technical specifications it is necessary to add requirements for HIV antibody/antigen combined tests and further specification of the sample requirements for certain assays.
The Annex to Decision 2002/364/EC should therefore be amended accordingly and, for the purpose of clarity, be replaced.
Manufacturers whose devices are already on the market should be given a transitional period in order to adapt to the new common technical specifications. On the other hand, in the interest of public health, manufacturers who so wish should be able to apply the new common technical specifications before the expiry of the transitional period.
HAS ADOPTED THIS DECISION: